Clinical trial · Interventional
Study of the Functioning of Prospective Memory in Breast Cancer and the Influence of Sleep
NCT03420105CI-TRIAL-00043884PROSOM-KcompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The results of this study will contribute to a better understanding of prospective memory deficit processes in breast cancer in relation to sleep disorders frequently reported in this pathology. In the long term, a better understanding will make it possible to envisage appropriate treatments to compensate for these memory difficulties and to improve the autonomy of the patients.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Memory Disorders | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Hormonotherapy | Drug | — | UNRESOLVED |
| Neuropsychological, psycho-pathological and quality of life assessments | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- OTHER
- label
- Group A
- description
- Patients perform neuropsychological, psycho-pathological and quality of life assessments, and sleep tests
- interventionNames
- Other: Neuropsychological, psycho-pathological and quality of life assessments
- Drug: Hormonotherapy
- type
- OTHER
- label
- Group B
- description
- Patients perform neuropsychological, psycho-pathological and quality of life assessments, and sleep tests
- interventionNames
- Other: Neuropsychological, psycho-pathological and quality of life assessments
- type
- OTHER
- label
- Healthy volunteers
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * Major patients under the age of 70; * Patients who have been treated by surgery or radiotherapy for non-metastatic breast cancer * Radiotherapy completed for about 6 months * Level of study 3 "end of primary studies" minimum (Barbizet scale); * French mother tongue; * Menopausal women for at least 1 year before the selection visit * Absence of primary cancer of the central nervous system or brain metastases; * Absence of previous neurological damage; * Absence of personality disorders and progressive psychiatric pathology; * Having signed the informed consent to participate in the study. Exclusion Criteria: * Primary cancer other than breast * Metastatic cancer * Treated by chemotherapy * Cognitive function disorders pre-existing to cancer diagnosis * Patients with paraneoplastic syndrome; * Evolutionary psychiatric pathology; * Refusal of participation; * Patients unable to respond to cognitive tests; * Drug use or excessive consumption of alcohol.
References
Publications (2)
- DERIVEDElia C, Perrier J, Duivon M, Rehel S, Gernier F, Fernette M, Doidy F, Clochon P, Grellard JM, Christy F, Segura-Djezzar C, Geffrelot J, Emile G, Allouache D, Viader F, Levy C, Joly F, Eustache F, Giffard B. Links between nocturnal hypoxia and cognitive function in breast cancer. Sci Rep. 2025 Nov 27;15(1):42405. doi: 10.1038/s41598-025-26591-z. PMID 41309988
- DERIVEDDuivon M, Perrier J, Joly F, Licaj I, Grellard JM, Clarisse B, Levy C, Fleury P, Madeleine S, Lefevre N, Rauchs G, Lecouvey G, Fraisse F, Viader F, Eustache F, Desgranges B, Giffard B. Impact of breast cancer on prospective memory functioning assessed by virtual reality and influence of sleep quality and hormonal therapy: PROSOM-K study. BMC Cancer. 2018 Sep 3;18(1):866. doi: 10.1186/s12885-018-4762-2. PMID 30176833